February 3, 2022
Structure and Content of an EU MAA
Structure and Content of an EU MAA The requirements related to MAAs in the EU are set out in Volume 2 of the Rules Governing Medicinal Products in the European Union (Eudralex), which is known as the Notice to Applicants. The Notice to Applicants has no legal force and gives the coordinated perspective of the…
Read more
POSTED BY
contact
February 2, 2022
The EU Marketing Authorisation Application
The Eu Marketing Authorization Application Part 1 – Format And Content Of Application Since 1995, ICH has been striving to develop common, agreed content and structure for the key data sections (SAFETY, QUALITY, and EFFICACY) of regulatory submissions for drug products, to reduce the workload and duplicated data gathering that was required to develop a…
Read more POSTED BY
contact
January 25, 2022
Discharging Routine Duties and the QP Code of Practice
Discharging Routine Duties and the QP Code of Practice Assuming the QP were to choose to do this large number of things themselves on a one-by-one basis, it would be hard to deliver more than 5 to 10 batches each week. The QP has no other option except to assign some of these obligations to partners. In any…
Read more POSTED BY
contact
December 28, 2021
Routine Duties of the Qualified Person
Routine Duties of the Qualified Person It was already covered in the previous blog the extent of the legal responsibilities of the Qualified Person was already covered in the previous blog. However, they do not cover the total professional responsibilities of the QP. The regulatory authorities’ perception of the routine duties of the Qualified Person…
Read more POSTED BY
contact
December 15, 2021
Verification of Compliance of Investigational Medicinal Products with Good Clinical and Manufacturing Practice
Verification of Compliance of Investigational Medicinal Products with Good Clinical and Manufacturing Practice The investigations will be led by the skilled power of the Member State concerned, which will illuminate the Agency; they will be completed for the benefit of the Community, and the outcomes will be in the interest of the Community, and the…
Read more POSTED BY
contact
December 11, 2021
Suspension of the Trial or Infringements
Suspension of the Trial or Infringements Infringements Before the Member State arrives at its choice, it will, except where there is a fast-approaching danger, ask for the support of, or potentially the examiner for their viewpoint, to be conveyed inside multi-week. For this situation, the competent authority concerned will forthwith inform the other able specialists,…
Read more POSTED BY
contact
December 9, 2021
Clinical Trials and the Ethics Committee
Clinical Trials and the Ethics Committee For the preparation of its opinion, the Ethics Committee shall consider the following: the importance of the clinical trial and the trial design; whether the evaluation of the anticipated benefits and risks is satisfactory and whether the conclusions are justified; the protocol; the suitability of the investigator and supporting…
Read more POSTED BY
contact
December 2, 2021
Clinical Trials on Incapacitated Adults Not Able to Give Informed Legal Consent
Clinical Trials on Incapacitated Adults Not Able to Give Informed Legal Consent Clinical Trials on Incapacitated Adults Not Able to Give Informed Legal Consent On account of different people being unequipped to give informed, lawful consent, all applicable necessities recorded for people equipped to give such consent will apply. Notwithstanding these necessities, consideration in clinical…
Read more POSTED BY
contact
December 1, 2021
Clinical Trial on Minors
Clinical Trial on Minors The protection of clinical trial subjects, the directive shall apply without prejudice to the national provisions on the protection of clinical trial subjects if they are more comprehensive than the provisions of this Directive and consistent with the procedures and time-scales specified therein. Member states shall, insofar as they have not…
Read more POSTED BY
contact
November 24, 2021
Manufacture and Import of Investigational Medicinal Product
Manufacture and Import of Investigational Medicinal Product The authorisation shall be required for both total and partial manufacture and for the various processes of dividing up, packaging, and presentation. To obtain this authorisation, the applicant must meet at least the following requirements: Specify the types of products to be manufactured or imported and the manufacturing…
Read more POSTED BY